Apellis Pharmaceuticals
APLS
APLS
133 hedge funds and large institutions have $1.34B invested in Apellis Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
19% more call options, than puts
Call options by funds: $43.1M | Put options by funds: $36M
5.29% more ownership
Funds ownership: 63.4% → 68.69% (+5.3%)
3% more funds holding
Funds holding: 129 → 133 (+4)
Holders
133
Holding in Top 10
4
Calls
$43.1M
Puts
$36M
Top Buyers
| 1 | +$34.1M | |
| 2 | +$22.9M | |
| 3 | +$21M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$17M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15.3M |
Top Sellers
| 1 | -$65.2M | |
| 2 | -$16.6M | |
| 3 | -$15M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.2M |
| 5 |
Morgan Stanley
New York
|
-$8.87M |